JWEL TOR Week ended 31 Jul 2026

Weekly Investor Report

Jamieson Wellness Inc. · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 41.35 CAD
1.2% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 13.6% above the Trend Line and sits at 85.8% of its 52-week range. The latest completed week returned 1.2%, after a -1.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers. The latest news-sentiment score is 53/100.

Setup score 62 out of 100
Latest Close 41.35 CAD 31 Jul 2026
1W Return 1.2% latest completed week
4W Return -1.5% short-term follow-through
12W Return 17.4% quarterly tape
Trend Breadth 40.4% 21 of 52 weeks active
Volume Ratio 1.2x vs 13-week average
What is working
  • The trend backdrop is active with a 9-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 2 reversal markers appear in the recent smart-money tape.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.2% Latest completed week; four-week move -1.5%. Indicator stack 53/75 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Positive 55.94% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 53/100 16 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 13.6% above the Trend Line and sits at 85.8% of its 52-week range. The latest completed week returned 1.2%, after a -1.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.2x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8012-week average 0.39

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership6/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.80Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -1.5% over four weeks, 17.4% over 12 weeks, and 25.3% over one year. The current trend has remained active for 9 consecutive weeks.

Performance by holding period

1W1.2%
4W-1.5%
12W17.4%
26W20.1%
52W25.3%
Active trend streak9 weeks
Active weeks in one year21
Trend breadth40.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.26Latest activity-pressure read.
Pressure change26.1%Four-week change in activity pressure.
Leadership5.55Latest relative-leadership reading.
RS change-15.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 94% Model confidence 90%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength21/100Blend of value, momentum, and quality. Underlying universe rank 80; rank 1 is best.
Value18/100Relative valuation strength. Underlying universe rank 83; rank 1 is best.
Quality76/100Profitability and accounting quality. Underlying universe rank 25; rank 1 is best.
Momentum33/100Medium-term price momentum. Underlying universe rank 68; rank 1 is best.
Growth77/100Revenue and earnings growth. Underlying universe rank 24; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework47/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
30.1x
Price divided by trailing earnings.
Price / sales
2.1x
Market value relative to trailing revenue.
EV / EBITDA
18.0x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
2.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
40.9%
Gross profit retained from each unit of revenue.
Operating margin
12.5%
Operating profit retained from revenue.
Free-cash-flow margin
7.1%
Free cash flow generated from revenue.
Return on invested capital
8.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
12.0%
Latest one-year revenue growth.
EPS growth
21.8%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
34.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.3%
Cash dividends relative to market value.
Buyback yield
8.2%
Net share repurchases relative to market value.
Shareholder yield
10.5%
Dividend yield plus net buyback yield.
Net debt / EBITDA
3.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment53/100

Weighted news tone is neutral across 16 relevant articles.

3 positive · 12 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-3.5%Distance below the 52-week high.
13-week volatility3.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher17 of 269 weeks finished lower.
Best week+12.4%Week of 26 Jun.
Worst week-4.6%Week of 6 Mar.
Latest week+1.2%Week of 31 Jul.

Shape of recent returns

Strong gains3
Modest gains14
Flat weeks0
Modest losses7
Sharp losses2
Recent vol3.6%13-week weekly-return volatility.
Base vol3.4%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew2.4% / -2.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape62/100

Trend, activity pressure, participation, and risk combine to a 62/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 9/12, activity pressure 7/12, relative leadership 6/12.

Activity pressure 0.80; 2 reversal markers Next-Week ExpectancyPositive 55.94%

Next-week expectancy is positive with a 55.94% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors36/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 4; Small Cap Core rank 76 SVQF47/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 159.5 of 298 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment53/100

Weighted news tone is neutral across 16 relevant articles.

Jamieson Wellness (TSX:JWEL) Reframes Growth Stocks Through Currency Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202641.35 CAD1.2%36.41 CAD31.60 CAD1.265.55419.0KOn
24 Jul 202640.87 CAD-2.8%36.14 CAD31.50 CAD1.353.82461.6KOn
17 Jul 202642.03 CAD0.7%35.88 CAD31.42 CAD1.336.96342.6KOn
10 Jul 202641.75 CAD-0.5%35.57 CAD31.32 CAD1.236.02300.5KOn
3 Jul 202641.96 CAD2.3%35.29 CAD31.23 CAD1.006.59426.9KOn
26 Jun 202641.02 CAD12.4%35.02 CAD31.13 CAD0.554.83178.4KOn
19 Jun 202636.48 CAD0.9%34.79 CAD31.04 CAD0.15-6.96264.0KOn
12 Jun 202636.16 CAD1.8%34.70 CAD30.99 CAD-0.24-8.1357.3KOn
5 Jun 202635.53 CAD0.3%34.66 CAD30.94 CAD-0.45-8.84125.7KOn
29 May 202635.41 CAD1.3%34.63 CAD30.88 CAD-0.36-10.57415.3KOff
22 May 202634.97 CAD2.5%34.60 CAD30.84 CAD-0.38-11.40308.5KOff
15 May 202634.13 CAD-3.1%34.58 CAD30.80 CAD-0.36-12.36539.6KOff
8 May 202635.21 CAD2.4%34.57 CAD30.77 CAD-0.41-10.67613.9KOff
1 May 202634.37 CAD1.3%34.54 CAD30.73 CAD-0.51-12.69502.2KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.